| Application no. and date | 03739557.1 (espacenet) (Federated) (European Patent Register), 20030212 | | Patent/reg. no. and date | DK/EP 1474114, 20100120 | | Publication date | 20041110 | | Priority no. and date | GB 0203296, 20020212, GB 0203298, 20020212, GB 0203297, 20020212 | | EP pub. no. and date |
EP 1474114 20041110 | | Effective date | | | Applicant/owner | Glaxo Group Limited, 980 Great West Road
Brentford, Middlesex TW8 9GS, GB | | Applicant ref. no. | P81000453DK00E | | Inventor | MARTINI, Luigi
GlaxoSmithKline, New Frontiers Science Park South
Third Avenue
Harlow, Essex CM19 5AW, GB,
WILLY, Helen, Anne
GlaxoSmithKline, New Frontiers Science Park South
Third Avenue
Harlow, Essex CM19 5AW, GB,
RE, Vincenzo
GlaxoSmithKline, GSK House
980 Great West Road
Brentford, Middlesex, TW8 9GS, GB,
LI, Chi, Leung
GlaxoSmithKline, Park Road, Ware
Hertfordshire, SG12 0DP, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 9/44 (2006.01) | | Title | Oral doseringsform til reguleret frigivelse af et lægemiddel | | Int. application no. | GB2003000594 | | Int. publication no. | WO2003068195 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
